BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 7512569)

  • 1. Fibroblast growth factor receptor (FGFR) 3. Alternative splicing in immunoglobulin-like domain III creates a receptor highly specific for acidic FGF/FGF-1.
    Chellaiah AT; McEwen DG; Werner S; Xu J; Ornitz DM
    J Biol Chem; 1994 Apr; 269(15):11620-7. PubMed ID: 7512569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FGFR3IIIS: a novel soluble FGFR3 spliced variant that modulates growth is frequently expressed in tumour cells.
    Sturla LM; Merrick AE; Burchill SA
    Br J Cancer; 2003 Oct; 89(7):1276-84. PubMed ID: 14520460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple structural elements determine ligand binding of fibroblast growth factor receptors. Evidence that both Ig domain 2 and 3 define receptor specificity.
    Zimmer Y; Givol D; Yayon A
    J Biol Chem; 1993 Apr; 268(11):7899-903. PubMed ID: 7681832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibroblast growth factor receptor-4 shows novel features in genomic structure, ligand binding and signal transduction.
    Vainikka S; Partanen J; Bellosta P; Coulier F; Birnbaum D; Basilico C; Jaye M; Alitalo K
    EMBO J; 1992 Dec; 11(12):4273-80. PubMed ID: 1385111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel form of fibroblast growth factor receptor 2. Alternative splicing of the third immunoglobulin-like domain confers ligand binding specificity.
    Dell KR; Williams LT
    J Biol Chem; 1992 Oct; 267(29):21225-9. PubMed ID: 1400433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a novel variant form of fibroblast growth factor receptor 3 (FGFR3 IIIb) in human colonic epithelium.
    Murgue B; Tsunekawa S; Rosenberg I; deBeaumont M; Podolsky DK
    Cancer Res; 1994 Oct; 54(19):5206-11. PubMed ID: 7923141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mapping ligand binding domains in chimeric fibroblast growth factor receptor molecules. Multiple regions determine ligand binding specificity.
    Chellaiah A; Yuan W; Chellaiah M; Ornitz DM
    J Biol Chem; 1999 Dec; 274(49):34785-94. PubMed ID: 10574949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel form of FGF receptor-3 using an alternative exon in the immunoglobulin domain III.
    Avivi A; Yayon A; Givol D
    FEBS Lett; 1993 Sep; 330(3):249-52. PubMed ID: 8375495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and biological activity of mouse fibroblast growth factor-9.
    Santos-Ocampo S; Colvin JS; Chellaiah A; Ornitz DM
    J Biol Chem; 1996 Jan; 271(3):1726-31. PubMed ID: 8576175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heparan sulfate fibroblast growth factor receptor complex: structure-function relationships.
    McKeehan WL; Kan M
    Mol Reprod Dev; 1994 Sep; 39(1):69-81; discusison 81-2. PubMed ID: 7999363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The nuclear trafficking of extracellular fibroblast growth factor (FGF)-1 correlates with the perinuclear association of the FGF receptor-1alpha isoforms but not the FGF receptor-1beta isoforms.
    Prudovsky IA; Savion N; LaVallee TM; Maciag T
    J Biol Chem; 1996 Jun; 271(24):14198-205. PubMed ID: 8662999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-affinity binding sites for related fibroblast growth factor ligands reside within different receptor immunoglobulin-like domains.
    Cheon HG; LaRochelle WJ; Bottaro DP; Burgess WH; Aaronson SA
    Proc Natl Acad Sci U S A; 1994 Feb; 91(3):989-93. PubMed ID: 8302878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell type-specific inhibition of keratinocyte collagenase-1 expression by basic fibroblast growth factor and keratinocyte growth factor. A common receptor pathway.
    Pilcher BK; Gaither-Ganim J; Parks WC; Welgus HG
    J Biol Chem; 1997 Jul; 272(29):18147-54. PubMed ID: 9218449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alternately spliced NH2-terminal immunoglobulin-like Loop I in the ectodomain of the fibroblast growth factor (FGF) receptor 1 lowers affinity for both heparin and FGF-1.
    Wang F; Kan M; Yan G; Xu J; McKeehan WL
    J Biol Chem; 1995 Apr; 270(17):10231-5. PubMed ID: 7730327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of residues important both for primary receptor binding and specificity in fibroblast growth factor-7.
    Sher I; Lang T; Lubinsky-Mink S; Kuhn J; Adir N; Chatterjee S; Schomburg D; Ron D
    J Biol Chem; 2000 Nov; 275(45):34881-6. PubMed ID: 10950949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exon III splicing switch of fibroblast growth factor (FGF) receptor-2 and -3 can be induced by FGF-1 or FGF-2.
    Scotet E; Houssaint E
    Oncogene; 1998 Jul; 17(1):67-76. PubMed ID: 9671315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibroblast growth factor receptors (FGFRs) localize in different cellular compartments. A splice variant of FGFR-3 localizes to the nucleus.
    Johnston CL; Cox HC; Gomm JJ; Coombes RC
    J Biol Chem; 1995 Dec; 270(51):30643-50. PubMed ID: 8530501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FGF-8 isoforms activate receptor splice forms that are expressed in mesenchymal regions of mouse development.
    MacArthur CA; Lawshé A; Xu J; Santos-Ocampo S; Heikinheimo M; Chellaiah AT; Ornitz DM
    Development; 1995 Nov; 121(11):3603-13. PubMed ID: 8582274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of fibroblast growth factor 9 (FGF9) as a high affinity, heparin dependent ligand for FGF receptors 3 and 2 but not for FGF receptors 1 and 4.
    Hecht D; Zimmerman N; Bedford M; Avivi A; Yayon A
    Growth Factors; 1995; 12(3):223-33. PubMed ID: 8619928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of FGF-receptors expressed by stromal and epithelial cells cultured from normal and hyperplastic prostates.
    Story MT; Hopp KA; Molter M; Meier DA
    Growth Factors; 1994; 10(4):269-80. PubMed ID: 7528517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.